Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

Different immunohistochemical (IHC) assays were approved for PD-L1 expression examination on tumor cells in qualification to immune-checkpoint inhibitors therapy in NSCLC patients. These assays have some similarities, but also very serious differences. We assessed 2 IHC tests for PD-L1 expression ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Paweł, Jarosz, Bożena, Kucharczyk, Tomasz, Grenda, Anna, Reszka, Katarzyna, Pankowski, Juliusz, Wojas-Krawczyk, Kamila, Nicoś, Marcin, Szumiło, Justyna, Trojanowski, Tomasz, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610002/
https://www.ncbi.nlm.nih.gov/pubmed/28969070
http://dx.doi.org/10.18632/oncotarget.19724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610002/
https://www.ncbi.nlm.nih.gov/pubmed/28969070
http://dx.doi.org/10.18632/oncotarget.19724

Ejemplares similares